Senior insider sale
Chief Financial Officer at AMYLYX PHARMACEUTICALS, INC. — senior position signals high conviction
$349.8K
10.81K shares
What this filing means
FRATES JAMES M plans to sell 10.81K shares of AMYLYX PHARMACEUTICALS, INC. valued at approximately $349.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/11/2026ACC: 0001193125-26-389246
Officer· Chief Financial Officer
Since Jan 2022
10.81K
Shares to sell
$349.8K
Approx. market value
22.81K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Vesting of Performance-based Restricted Stock Units
N/A
9/10/2026
22.81KTotal acquired22.81K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/10/2026 | Vesting of Performance-based Restricted Stock Units N/A | 22.81K | — |
| Total | 22.81K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
10.81K
Market value
$349.8K
9/10/2026
Total
Units
10.81K
Value
$349.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/10/2026 | 10.81K | $349.8K | NASDAQ | Planned |
| Total | 10.81K | $349.8K | ||